Genomic profiling of biosynthetic potentials of medicinal secondary metabolites for ‘Aliisedimentitalea scapharcae’ KCTC 42119T, isolated from ark shell

Microorganisms living with higher organisms are valuable sources of bioactive substances like antibiotics, which could assist them competing for more and better nutrients or space. Here, we focused on a marine animal-associated bacterium, ‘Aliisedimentitalea scapharcae’ KCTC 42119^T, which was isolated from ark shell collected from Gang-Jin bay of South Korea. We evaluated its biosynthetic potentials of medicinal secondary metabolites by de novo genome sequencing. The complete genome of strain KCTC 42119^T sequenced is 5,083,900 bp and is comprised of one circular chromosome and four circular plasmids. Functional genome analysis by antiSMASH v7.1.0 showed that there are nine biosynthetic gene clusters encoded on the chromosome. The annotated secondary metabolites include antibiotic corynecin, cytoprotective ectoine and antineoplastic ET-743 (Yondelis), which suggested strain KCTC 42119^T possesses potentials to synthesize a series of secondary metabolites of pharmaceutical utility. Genome analysis of ‘A. scapharcae’ also provides more insights into mining bioactive substances from animal-associated microorganisms.